Losartan Drug Classification
Losartan is an angiotensin II receptor blocker (ARB), specifically a selective angiotensin II type 1 (AT1) receptor antagonist. 1
Mechanism of Action
- Losartan selectively and completely blocks the binding of angiotensin II at the angiotensin type 1 (AT1) receptor, which represents a unique mechanism of action different from all other classes of antihypertensive agents 2
- This provides a more specific and complete blockade of the actions of angiotensin II than renin or ACE inhibitors 3
- The AT1 receptor blockade inhibits all well-known effects of angiotensin II, including vasoconstriction, aldosterone release, renin release (negative feedback), and stimulation of thirst 4
Chemical Structure and Pharmacology
- Losartan potassium is a non-peptide molecule, chemically described as 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-yl-phenyl)benzyl]-imidazole-5-methanol monopotassium salt with molecular formula C22H22ClKN6O 1
- Losartan is the prototype and first of this new class of AT1-selective receptor antagonists to reach clinical use 5, 6
- The parent compound has moderate affinity for the AT1 receptor (competitive inhibition) and is rapidly converted via oxidation in the liver to a more potent metabolite (E3174) with 20- to 30-times greater affinity for the AT1 receptor (non-competitive inhibition) 5
Clinical Context
- Guidelines classify losartan within the ARB drug class alongside other agents such as valsartan, candesartan, and irbesartan for treatment of hypertension, heart failure, and diabetic nephropathy 7
- The JNC 7 guidelines specifically identify losartan as an ARB when comparing it to other antihypertensive drug classes including ACE inhibitors, beta-blockers, calcium channel blockers, and diuretics 7